170 related articles for article (PubMed ID: 32523897)
1. A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region.
Hajduczki A; Danielson DT; Elias DS; Bundoc V; Scanlan AW; Berger EA
Front Cell Infect Microbiol; 2020; 10():242. PubMed ID: 32523897
[TBL] [Abstract][Full Text] [Related]
2. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
3. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
[TBL] [Abstract][Full Text] [Related]
4. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
Ollerton MT; Berger EA; Connick E; Burton GF
J Virol; 2020 May; 94(10):. PubMed ID: 32161179
[TBL] [Abstract][Full Text] [Related]
5. Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry.
Khan SN; Sok D; Tran K; Movsesyan A; Dubrovskaya V; Burton DR; Wyatt RT
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976677
[TBL] [Abstract][Full Text] [Related]
6. Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells.
Davey BC; Pampusch MS; Cartwright EK; Abdelaal HM; Rakasz EG; Rendahl A; Berger EA; Skinner PJ
Front Immunol; 2022; 13():1032537. PubMed ID: 36582226
[TBL] [Abstract][Full Text] [Related]
7. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
8. HIV-Resistant and HIV-Specific CAR-Modified CD4
Maldini CR; Gayout K; Leibman RS; Dopkin DL; Mills JP; Shan X; Glover JA; Riley JL
Mol Ther; 2020 Jul; 28(7):1585-1599. PubMed ID: 32454027
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
Iwamoto N; Patel B; Song K; Mason R; Bolivar-Wagers S; Bergamaschi C; Pavlakis GN; Berger E; Roederer M
PLoS One; 2021; 16(3):e0248973. PubMed ID: 33752225
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
11. Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.
Hale M; Mesojednik T; Romano Ibarra GS; Sahni J; Bernard A; Sommer K; Scharenberg AM; Rawlings DJ; Wagner TA
Mol Ther; 2017 Mar; 25(3):570-579. PubMed ID: 28143740
[TBL] [Abstract][Full Text] [Related]
12. Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
Mao Y; Zhao C; Zheng P; Zhang X; Xu J
Immunotherapy; 2021 Feb; 13(2):177-184. PubMed ID: 33225803
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
14. Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.
Leibman RS; Richardson MW; Ellebrecht CT; Maldini CR; Glover JA; Secreto AJ; Kulikovskaya I; Lacey SF; Akkina SR; Yi Y; Shaheen F; Wang J; Dufendach KA; Holmes MC; Collman RG; Payne AS; Riley JL
PLoS Pathog; 2017 Oct; 13(10):e1006613. PubMed ID: 29023549
[TBL] [Abstract][Full Text] [Related]
15. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
[TBL] [Abstract][Full Text] [Related]
16. Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.
Debelec-Butuner B; Quitt O; Schreiber S; Momburg F; Wisskirchen K; Protzer U
Front Immunol; 2022; 13():1029214. PubMed ID: 36405686
[TBL] [Abstract][Full Text] [Related]
17. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
[TBL] [Abstract][Full Text] [Related]
18. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
19. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
[TBL] [Abstract][Full Text] [Related]
20. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
